CLINICAL TRIALS PROFILE FOR GAMMAPLEX
✉ Email this page to a colleague
All Clinical Trials for GAMMAPLEX
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02199925 ↗ | An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum | Unknown status | Bio Products Laboratory | Phase 4 | 2013-06-01 | If autism is the consequence of a chronic inflammatory process preventing the infant brain from forming the proper neural connections, then treatment that reduces inflammation might have a positive impact on autism. IGIV treatment has been known to suppress inflammation and has been used in the treatment of inflammatory conditions and autoimmune diseases. |
NCT02199925 ↗ | An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum | Unknown status | Isaac Melamed | Phase 4 | 2013-06-01 | If autism is the consequence of a chronic inflammatory process preventing the infant brain from forming the proper neural connections, then treatment that reduces inflammation might have a positive impact on autism. IGIV treatment has been known to suppress inflammation and has been used in the treatment of inflammatory conditions and autoimmune diseases. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GAMMAPLEX
Condition Name
Clinical Trial Locations for GAMMAPLEX
Trials by Country
Clinical Trial Progress for GAMMAPLEX
Clinical Trial Phase
Clinical Trial Sponsors for GAMMAPLEX
Sponsor Name